Jianmin Pharmaceutical Group Co Ltd (600976) — Long-term Investment Intensity
Jianmin Pharmaceutical Group Co Ltd (600976) has a Long-term Investment Intensity of 12.7% as of September 2019. Long-term investments of CN¥233.19 Million represent 12.7% of total assets of CN¥1.83 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600976 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Jianmin Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Jianmin Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 12.7%, reflecting long-term investments of CN¥233.19 Million against total assets of CN¥1.83 Billion CNY. Explore 600976 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Jianmin Pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Jianmin Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Jianmin Pharmaceutical Group Co Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 13.4% | CN¥230.21 Million | CN¥1.72 Billion | ▲ +3.2 pp |
| 2017 | 10.2% | CN¥196.20 Million | CN¥1.92 Billion | ▲ +2.2 pp |
| 2016 | 8.0% | CN¥145.37 Million | CN¥1.81 Billion | ▲ +2.6 pp |
| 2015 | 5.4% | CN¥86.52 Million | CN¥1.60 Billion | — |